Nayzilam is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as a short-term treatment for seizure clusters in people 12 years of age and older. Nayzilam is also known by its drug name, midazolam.
Nayzilam is a benzodiazepine. It is believed that Nayzilam works in cases of epilepsy by inhibiting nerve signals.
How do I take it?
Nayzilam is administered as a nasal spray during a seizure cluster episode. Nayzilam cannot be used more than once in three days or five times in one month.
Nayzilam is supplied as a single-dose nasal spray unit.
The FDA-approved label for Nayzilam lists common side effects including drowsiness, headache, nasal discomfort, throat irritation, and runny nose.
Rare but serious side effects listed for Nayzilam include impaired thinking, judgment, and reaction time. Antiepileptic drugs, including Nayzilam, can increase the risk of suicidal thoughts. Taking Nayzilam with opioids or alcohol can cause severe drowsiness, breathing problems, coma, and death.
For more details about this treatment, visit:
Nayzilam — UCB